Cite
APA Citation
Prandoni, P., Lensing, A. W., Prins, M. H., Gebel, M., Pap, A. F., Homering, M., Bauersachs, R., Beyer-Westendorf, J., Bounameaux, H., Cohen, A. T., Davidson, B. L., van Bellen, B., Verhamme, P., Wells, P. S., Yuan, Z., Levitan, B., & Weitz, J. I. (2018). benefits and risks of extended treatment of venous thromboembolism with rivaroxaban or with aspirin. Thrombosis research, (168), 121–129. http://access.bl.uk/ark:/81055/vdc_100066544130.0x000053